Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine.

Area of Science:

• Pharmacometrics
• Econometrics
• Statistical Modeling

Background:

• Population pharmacokinetic (PopPK) analysis is crucial for understanding drug disposition in diverse patient populations.
• Nonlinear mixed-effects (NLME) models are widely used but estimating the random effects density can be challenging.
• Existing methods may lack flexibility in characterizing complex random effects distributions.

Purpose of the Study:

• To introduce and evaluate the seminonparametric (SNP) method for population pharmacokinetic analysis.
• To demonstrate the SNP method's capability in estimating the full random effects density and fixed effects simultaneously.
• To present a graphical model-building strategy utilizing the SNP approach.

Main Methods:

• Application of the seminonparametric (SNP) method, originating from econometrics, to PopPK data.
• Utilizing maximum likelihood estimation for simultaneous estimation of fixed and nonparametric random effects.
• Development and illustration of a graphical strategy for model building with SNP.

Main Results:

• The SNP method provides smooth, nonparametric estimates of the entire random effects density.
• Simultaneous estimation of fixed effects is achieved through maximum likelihood.
• The method was successfully applied to a population analysis of oral quinidine plasma levels in 136 patients.

Conclusions:

• The seminonparametric (SNP) method is a viable and powerful tool for population pharmacokinetic analysis.
• SNP modeling offers enhanced estimation of random effects distributions compared to traditional methods.
• The proposed graphical strategy facilitates model building and interpretation in PopPK studies.